MCID: SPN033
MIFTS: 37

Spontaneous Ocular Nystagmus malady

Categories: Neuronal diseases, Eye diseases

Aliases & Classifications for Spontaneous Ocular Nystagmus

Aliases & Descriptions for Spontaneous Ocular Nystagmus:

Name: Spontaneous Ocular Nystagmus 12 14 69
Visual Deprivation Nystagmus 12
Searching Eye Movements 12
Nystagmus, Pathologic 42
Ocular Nystagmus 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11771
ICD10 33 H55.03
ICD9CM 35 379.53
MeSH 42 D009759
UMLS 69 C0271384

Summaries for Spontaneous Ocular Nystagmus

MalaCards based summary : Spontaneous Ocular Nystagmus, also known as visual deprivation nystagmus, is related to pathologic nystagmus and epicondylitis, and has symptoms including deficiencies of smooth pursuit movements An important gene associated with Spontaneous Ocular Nystagmus is FRMD7 (FERM Domain Containing 7), and among its related pathways/superpathways are Metabolism and DAG and IP3 signaling. The drugs Dopamine and Gabapentin have been mentioned in the context of this disorder. Affiliated tissues include eye, and related phenotype is Increased shRNA abundance (Z-score > 2).

Related Diseases for Spontaneous Ocular Nystagmus

Diseases related to Spontaneous Ocular Nystagmus via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 28)
id Related Disease Score Top Affiliating Genes
1 pathologic nystagmus 11.3
2 epicondylitis 10.1 FUT2 MED12
3 bleeding disorder, platelet-type, 15 10.0 CALM1 CALM2 CALM3
4 microphthalmia with limb anomalies 10.0 CALM1 CALM2 CALM3
5 subclavian steal syndrome 10.0 CALM1 CALM2 CALM3
6 leukemia, acute lymphoblastic 2 10.0 CALM1 CALM2 CALM3
7 short stature with microcephaly and distinctive facies 10.0 CALM1 CALM2 CALM3
8 neuropathy, hereditary sensory and autonomic, type ii 10.0 CALM1 CALM2 CALM3
9 dumping syndrome 9.9 CALM1 CALM2 CALM3
10 arthropathy 9.9 CALM1 CALM2 CALM3
11 chronic dacryoadenitis 9.9 CALM1 CALM2 CALM3
12 retinitis pigmentosa 20 9.9 CALM1 CALM2 CALM3
13 aspiration pneumonia 9.9 CALM1 CALM2 CALM3
14 familial sick sinus syndrome 9.9 CALM1 CALM2 CALM3
15 lipodystrophy, familial partial, 2 9.9 CALM1 CALM2 CALM3
16 ciliary dyskinesia, primary, 11 9.9 CALM1 CALM2 CALM3
17 deafness, autosomal dominant 2a 9.9 CALM1 CALM2 CALM3
18 congenital hypothyroidism 9.9 CALM1 CALM2 CALM3
19 encephalomalacia 9.9 CALM1 CALM3
20 distal arthrogryposis 9.9 CALM1 CALM2 CALM3
21 partial of retinal vein occlusion 9.9 CALM1 CALM2 CALM3
22 neurofibroma 9.9 CALM1 CALM2 CALM3
23 autosomal dominant nocturnal frontal lobe epilepsy 2 9.9 CALM1 CALM2 CALM3
24 mastoiditis 9.8 CALM1 CALM2 CALM3
25 atrial fibrillation, familial, 3 9.8 CALM1 CALM2 CALM3
26 hyperthyroxinemia 9.8 CALM1 CALM2 CALM3
27 lateral medullary syndrome 9.6
28 regular astigmatism 8.8 CALB1 CALM1 CALM2 CALM3 CSPG5 FRMD7

Graphical network of the top 20 diseases related to Spontaneous Ocular Nystagmus:



Diseases related to Spontaneous Ocular Nystagmus

Symptoms & Phenotypes for Spontaneous Ocular Nystagmus

UMLS symptoms related to Spontaneous Ocular Nystagmus:


deficiencies of smooth pursuit movements

GenomeRNAi Phenotypes related to Spontaneous Ocular Nystagmus according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-101 9.5 POMC CALB1 CALM2
2 Increased shRNA abundance (Z-score > 2) GR00366-A-102 9.5 POMC
3 Increased shRNA abundance (Z-score > 2) GR00366-A-127 9.5 POMC
4 Increased shRNA abundance (Z-score > 2) GR00366-A-128 9.5 CALM2
5 Increased shRNA abundance (Z-score > 2) GR00366-A-130 9.5 CALB1
6 Increased shRNA abundance (Z-score > 2) GR00366-A-214 9.5 CALB1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-29 9.5 POMC
8 Increased shRNA abundance (Z-score > 2) GR00366-A-32 9.5 POMC
9 Increased shRNA abundance (Z-score > 2) GR00366-A-85 9.5 CALB1 CALM2
10 Increased shRNA abundance (Z-score > 2) GR00366-A-88 9.5 POMC
11 Increased shRNA abundance (Z-score > 2) GR00366-A-9 9.5 POMC
12 Increased shRNA abundance (Z-score > 2) GR00366-A-99 9.5 CALB1

Drugs & Therapeutics for Spontaneous Ocular Nystagmus

Drugs for Spontaneous Ocular Nystagmus (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 66)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dopamine Approved Phase 4,Phase 2 51-61-6, 62-31-7 681
2
Gabapentin Approved, Investigational Phase 4,Phase 2 60142-96-3 3446
3
Memantine Approved, Investigational Phase 4,Phase 2 19982-08-2 4054
4
Brinzolamide Approved Phase 4 138890-62-7 68844
5 Analgesics Phase 4,Phase 2,Phase 1
6 Anti-Anxiety Agents Phase 4,Phase 2
7 Anticonvulsants Phase 4,Phase 2
8 Antimanic Agents Phase 4,Phase 2
9 Antiparkinson Agents Phase 4,Phase 2
10 calcium channel blockers Phase 4,Phase 2
11 Calcium, Dietary Phase 4,Phase 2
12 Central Nervous System Depressants Phase 4,Phase 2,Phase 3,Phase 1
13 Dopamine Agents Phase 4,Phase 2
14 Excitatory Amino Acid Antagonists Phase 4,Phase 2,Phase 1
15 Excitatory Amino Acids Phase 4,Phase 2,Phase 1
16 GABA Agents Phase 4,Phase 2
17
gamma-Aminobutyric Acid Phase 4,Phase 2 56-12-2 119
18 Neurotransmitter Agents Phase 4,Phase 2,Phase 1
19 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1
20 Psychotropic Drugs Phase 4,Phase 2
21 Tranquilizing Agents Phase 4,Phase 2
22 Carbonic Anhydrase Inhibitors Phase 4
23 Ophthalmic Solutions Phase 4
24 Pharmaceutical Solutions Phase 4,Phase 1,Phase 2
25 Tetrahydrozoline Phase 4
26 Anti-Bacterial Agents Phase 4
27 Anti-Infective Agents Phase 4
28 Gentamicins Phase 4
29
Bupivacaine Approved, Investigational Phase 2, Phase 3 2180-92-9, 38396-39-3 2474
30
Epinephrine Approved, Vet_approved Phase 2, Phase 3 51-43-4 5816
31 Anesthetics Phase 2, Phase 3,Phase 1
32 Anesthetics, Local Phase 2, Phase 3
33 Epinephryl borate Phase 2, Phase 3
34 Racepinephrine Phase 2, Phase 3
35
4-Aminopyridine Approved Phase 2 504-24-5 1727
36
Prednisone Approved, Vet_approved Phase 2 53-03-2 5865
37
Baclofen Approved Phase 1, Phase 2 1134-47-0 2284
38 Potassium Channel Blockers Phase 2
39 Anti-Inflammatory Agents Phase 2
40 Antineoplastic Agents, Hormonal Phase 2
41 glucocorticoids Phase 2
42 Hormone Antagonists Phase 2
43 Hormones Phase 2
44 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2
45
Ketamine Approved, Vet_approved Phase 1 6740-88-1 3821
46
Oxymetazoline Approved Phase 1 1491-59-4 4636
47
Phenylephrine Approved Phase 1 59-42-7 6041
48 Anesthetics, Dissociative Phase 1
49 Anesthetics, General Phase 1
50 Anesthetics, Intravenous Phase 1

Interventional clinical trials:

(show top 50) (show all 54)
id Name Status NCT ID Phase
1 Treatment of Pendular Nystagmus in OPT Completed NCT02466191 Phase 4
2 Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome Completed NCT01312402 Phase 4
3 Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function Recruiting NCT02415257 Phase 4
4 Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function Recruiting NCT02379754 Phase 4
5 Treatment of Geotropic Horizontal Canal Benign Paroxysmal Positional Vertigo Completed NCT01366430 Phase 3
6 Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo Completed NCT00810641 Phase 3
7 Bupivacaine Injection of Eye Muscles to Treat Strabismus Recruiting NCT01616108 Phase 2, Phase 3
8 Efficacy of SENS-111 in Patients Suffering From Acute Unilateral Vestibulopathy Not yet recruiting NCT03110458 Phase 2, Phase 3
9 4-Aminopyridine in Episodic Ataxia Type 2 Unknown status NCT01543750 Phase 2
10 Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus Completed NCT00661440 Phase 2
11 Eye Muscle Surgery to Treat Congenital Nystagmus Completed NCT00001866 Phase 2
12 Treatment of Pendular Nystagmus With Gabapentin and Memantine in Patients With Multiple Sclerosis Completed NCT01744444 Phase 2
13 Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo Completed NCT02046980 Phase 2
14 Prednisone Treatment for Vestibular Neuronitis Completed NCT00271791 Phase 2
15 Gene Therapy for Achromatopsia (CNGB3) Recruiting NCT03001310 Phase 1, Phase 2
16 Repeated Dose IV Baclofen Safety/Bioequivalence Study Not yet recruiting NCT02760992 Phase 1, Phase 2
17 Open-lable Extension Study on Safety and Efficacy of Neramexane to Treat Congenital and Acquired Nystagmus Terminated NCT00799942 Phase 2
18 Oral and IV Baclofen in Adult Volunteers Completed NCT01749319 Phase 1
19 A Blinded, Four-Way Crossover in Healthy Subjects to Assess EEG After Administration of Ketamine, Placebo and AZD6765 Terminated NCT01130909 Phase 1
20 Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo Unknown status NCT01822002
21 Safety and Feasibility of Using Epicall for Monitoring Pre-seizure Biomarkers Unknown status NCT01436695
22 Cross-over Comparison of Gabapentin and Memantine as Treatment for Acquired Nystagmus Completed NCT00928954
23 Screening for Studies on Nystagmus and Strabismus Completed NCT00001861
24 Effect of Vestibular Rehabilitation - a Randomized Controlled Trial Completed NCT00702832
25 Vestibular Evoked Myogenic Potentials in Benign Paroxysmal Positional Vertigo (VEMP in BPPV) Completed NCT01004913
26 Quantification of Prosthesis Penetration With Conebeam in Otosclerosis Completed NCT02901093
27 Vertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma Completed NCT02963896
28 Long-term Postoperative Outcomes After Bilateral Congenital Cataract Surgery in Eyes With Microphthalmos Completed NCT01818037
29 Telemedical Examination of a Three-Component Oculomotor Testing Battery Completed NCT02938221
30 Correlation of Gene Abnormalities and Clinical Manifestations of Aniridia Completed NCT00265590
31 Clinical Aspects of Patients With Benign Paroxysmal Positional Vertigo (BPPV) and Migraine Completed NCT02615314
32 Accuracy of a Diagnostic Algorithm for the Differential Diagnosis of Vertigo in the ED: the STANDING. Completed NCT02782962
33 Vasopressin and V2 Receptor in Meniere's Disease Completed NCT00599560
34 Evaluation and Treatment of Pediatric Eye Diseases Completed NCT00006422
35 Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy Completed NCT00422721
36 Evaluation and Treatment of Pediatric, Developmental, and Genetic Eye Diseases Completed NCT00076271
37 Relationship Between Musculoskeletal, Sensorimotor and Functional Factors and Nonspecific Chronic Neck Pain Completed NCT02789631
38 Gaze Holding in Cerebellar Patients Recruiting NCT02185313
39 Early Versus Delayed Surgery for Infantile Esotropia Recruiting NCT01166503
40 BPPV Treatment in Biaxial Rotational Chair Recruiting NCT01905800
41 The Effects of ProFoveate on Reducing Self-Stimulating Behaviors Recruiting NCT02088047
42 BPPV With CRP: Single Versus Multiple Cycles Recruiting NCT02701218
43 Study of the Effectiveness of Vestibular Stimulation Treatment in the Depressive Phase of Bipolar Disorder Recruiting NCT02778256
44 Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism Recruiting NCT00808106
45 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Recruiting NCT01793168
46 Chromosome 18 Clinical Research Center Recruiting NCT00227253
47 Functional Link Between Hippocampal and Vestibular Systems: a Pilot Study in Epilepsy Surgery Active, not recruiting NCT01285921
48 Expanded Access Study Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS), Congenital Myasthenic Syndrome (CMS), or Downbeat Nystagmus Patients Available NCT02189720
49 Helpfulness of the Vibration Test Performed in Room Light on Clients With Inner Ear Problems Enrolling by invitation NCT02626052
50 Simultaneous Recordings of Cervical and Ocular Vestibular-evoked Myogenic Potentials Enrolling by invitation NCT03049683

Search NIH Clinical Center for Spontaneous Ocular Nystagmus

Cochrane evidence based reviews: nystagmus, pathologic

Genetic Tests for Spontaneous Ocular Nystagmus

Anatomical Context for Spontaneous Ocular Nystagmus

MalaCards organs/tissues related to Spontaneous Ocular Nystagmus:

39
Eye

Publications for Spontaneous Ocular Nystagmus

Articles related to Spontaneous Ocular Nystagmus:

id Title Authors Year
1
Ginkgolide B accelerates vestibular compensation of spontaneous ocular nystagmus in guinea pig following unilateral labyrinthectomy. ( 7895826 )
1995
2
Injections of calmidazolium chloride into the ipsilateral medial vestibular nucleus or fourth ventricle reduce spontaneous ocular nystagmus following unilateral labyrinthectomy in guinea pigs. ( 8491266 )
1993

Variations for Spontaneous Ocular Nystagmus

Expression for Spontaneous Ocular Nystagmus

Search GEO for disease gene expression data for Spontaneous Ocular Nystagmus.

Pathways for Spontaneous Ocular Nystagmus

Pathways related to Spontaneous Ocular Nystagmus according to GeneCards Suite gene sharing:

(show top 50) (show all 77)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.93 CALM1 CALM2 CALM3 CSPG5 FUT2 MED12
2
Show member pathways
12.96 CALM1 CALM2 CALM3 POMC
3
Show member pathways
12.78 CALM1 CALM2 CALM3 POMC
4
Show member pathways
12.76 CALM1 CALM2 CALM3 CSPG5
5
Show member pathways
12.43 CALM1 CALM2 CALM3 POMC
6
Show member pathways
12.42 CALM1 CALM2 CALM3
7
Show member pathways
12.4 CALM1 CALM2 CALM3
8
Show member pathways
12.38 CALM1 CALM2 CALM3
9
Show member pathways
12.34 CALM1 CALM2 CALM3
10
Show member pathways
12.33 CALM1 CALM2 CALM3
11
Show member pathways
12.32 CALM1 CALM2 CALM3
12
Show member pathways
12.31 CALM1 CALM2 CALM3
13
Show member pathways
12.31 CALM1 CALM2 CALM3
14
Show member pathways
12.3 CALM1 CALM2 CALM3
15
Show member pathways
12.29 CALM1 CALM2 CALM3
16
Show member pathways
12.28 CALM1 CALM2 CALM3
17 12.26 CALM1 CALM2 CALM3
18
Show member pathways
12.25 CALM1 CALM2 CALM3
19
Show member pathways
12.24 CALM1 CALM2 CALM3
20
Show member pathways
12.23 CALM1 CALM2 CALM3
21
Show member pathways
12.23 CALM1 CALM2 CALM3
22
Show member pathways
12.22 CALM1 CALM2 CALM3
23
Show member pathways
12.2 CALM1 CALM2 CALM3
24
Show member pathways
12.2 CALM1 CALM2 CALM3 POMC
25
Show member pathways
12.16 CALM1 CALM2 CALM3
26
Show member pathways
12.16 CALM1 CALM2 CALM3
27
Show member pathways
12.16 CALM1 CALM2 CALM3
28
Show member pathways
12.13 CALM1 CALM2 CALM3
29 12.13 CALM1 CALM2 CALM3
30
Show member pathways
12.11 CALM1 CALM2 CALM3
31
Show member pathways
12.1 CALM1 CALM2 CALM3
32
Show member pathways
12.08 CALM1 CALM2 CALM3
33
Show member pathways
12.06 CALM1 CALM2 CALM3
34
Show member pathways
12.05 CALM1 CALM2 CALM3
35
Show member pathways
12.03 CALM1 CALM2 CALM3
36 12 CALM1 CALM2 CALM3
37 11.99 CALM1 CALM2 CALM3
38
Show member pathways
11.93 CALM1 CALM2 CALM3
39
Show member pathways
11.91 CALM1 CALM2 CALM3
40
Show member pathways
11.89 CALM1 CALM2 CALM3
41
Show member pathways
11.86 CALM1 CALM2 CALM3
42 11.84 CALM1 CALM2 CALM3
43 11.83 CALM1 CALM2 CALM3
44
Show member pathways
11.81 CALM1 CALM2 CALM3
45
Show member pathways
11.78 CALM1 CALM2 CALM3
46
Show member pathways
11.77 CALM1 CALM2 CALM3
47
Show member pathways
11.71 CALM1 CALM2 CALM3
48
Show member pathways
11.7 CALM1 CALM2 CALM3
49
Show member pathways
11.69 CALM1 CALM2 CALM3
50
Show member pathways
11.67 CALM1 CALM2 CALM3

GO Terms for Spontaneous Ocular Nystagmus

Cellular components related to Spontaneous Ocular Nystagmus according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 spindle GO:0005819 9.54 CALM1 CALM2 CALM3
2 vesicle GO:0031982 9.5 CALM1 CALM2 CALM3
3 spindle pole GO:0000922 9.43 CALM1 CALM2 CALM3
4 sarcomere GO:0030017 9.33 CALM1 CALM2 CALM3
5 spindle microtubule GO:0005876 9.13 CALM1 CALM2 CALM3
6 calcium channel complex GO:0034704 8.8 CALM1 CALM2 CALM3

Biological processes related to Spontaneous Ocular Nystagmus according to GeneCards Suite gene sharing:

(show all 29)
id Name GO ID Score Top Affiliating Genes
1 ion transmembrane transport GO:0034220 9.82 CALM1 CALM2 CALM3
2 Fc-epsilon receptor signaling pathway GO:0038095 9.81 CALM1 CALM2 CALM3
3 platelet degranulation GO:0002576 9.81 CALM1 CALM2 CALM3
4 muscle contraction GO:0006936 9.8 CALM1 CALM2 CALM3
5 response to calcium ion GO:0051592 9.8 CALM1 CALM2 CALM3
6 inositol phosphate metabolic process GO:0043647 9.79 CALM1 CALM2 CALM3
7 substantia nigra development GO:0021762 9.79 CALM1 CALM2 CALM3
8 protein methylation GO:0006479 9.78 CALM1 CALM2 CALM3
9 positive regulation of protein serine/threonine kinase activity GO:0071902 9.77 CALM1 CALM2 CALM3
10 Wnt signaling pathway, calcium modulating pathway GO:0007223 9.77 CALM1 CALM2 CALM3
11 regulation of heart rate GO:0002027 9.76 CALM1 CALM2 CALM3
12 positive regulation of peptidyl-threonine phosphorylation GO:0010800 9.75 CALM1 CALM2 CALM3
13 regulation of rhodopsin mediated signaling pathway GO:0022400 9.74 CALM1 CALM2 CALM3
14 regulation of nitric-oxide synthase activity GO:0050999 9.73 CALM1 CALM2 CALM3
15 positive regulation of protein autophosphorylation GO:0031954 9.72 CALM1 CALM2 CALM3
16 regulation of cytokinesis GO:0032465 9.71 CALM1 CALM2 CALM3
17 regulation of cardiac muscle contraction GO:0055117 9.7 CALM1 CALM2 CALM3
18 positive regulation of protein dephosphorylation GO:0035307 9.69 CALM1 CALM2 CALM3
19 glycogen catabolic process GO:0005980 9.67 CALM1 CALM2 CALM3
20 regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum GO:0010880 9.65 CALM1 CALM2 CALM3
21 regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion GO:0010881 9.63 CALM1 CALM2 CALM3
22 negative regulation of peptidyl-threonine phosphorylation GO:0010801 9.61 CALM1 CALM2 CALM3
23 positive regulation of phosphoprotein phosphatase activity GO:0032516 9.58 CALM1 CALM2 CALM3
24 detection of calcium ion GO:0005513 9.54 CALM1 CALM2 CALM3
25 negative regulation of ryanodine-sensitive calcium-release channel activity GO:0060315 9.5 CALM1 CALM2 CALM3
26 positive regulation of ryanodine-sensitive calcium-release channel activity GO:0060316 9.43 CALM1 CALM2 CALM3
27 regulation of cell communication by electrical coupling involved in cardiac conduction GO:1901844 9.33 CALM1 CALM2 CALM3
28 positive regulation of cyclic-nucleotide phosphodiesterase activity GO:0051343 9.13 CALM1 CALM2 CALM3
29 positive regulation of cyclic nucleotide metabolic process GO:0030801 8.8 CALM1 CALM2 CALM3

Molecular functions related to Spontaneous Ocular Nystagmus according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 calcium ion binding GO:0005509 9.81 CALB1 CALM1 CALM2 CALM3
2 protein domain specific binding GO:0019904 9.76 CALM1 CALM2 CALM3 MED12
3 Ras guanyl-nucleotide exchange factor activity GO:0005088 9.67 CALM1 CALM2 CALM3
4 ion channel binding GO:0044325 9.65 CALM1 CALM2 CALM3
5 ligand-gated ion channel activity GO:0015276 9.61 CALM1 CALM2 CALM3
6 protein serine/threonine kinase activator activity GO:0043539 9.58 CALM1 CALM2 CALM3
7 phospholipase binding GO:0043274 9.54 CALM1 CALM2 CALM3
8 titin binding GO:0031432 9.5 CALM1 CALM2 CALM3
9 thioesterase binding GO:0031996 9.43 CALM1 CALM2 CALM3
10 inositol-1,4,5-trisphosphate 3-kinase activity GO:0008440 9.33 CALM1 CALM2 CALM3
11 protein phosphatase activator activity GO:0072542 9.13 CALM1 CALM2 CALM3
12 N-terminal myristoylation domain binding GO:0031997 8.8 CALM1 CALM2 CALM3

Sources for Spontaneous Ocular Nystagmus

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....